Oficiálny časopis Slovenskej kardiologickej spoločnosti,
Slovenskej hypertenziologickej spoločnosti a Slovenskej asociácie srdcových arytmií

Cardiology Letters 2025, 34(5):288-290

Pivotal clinical trials shaping contemporary cardiology practice. News from the European Society of Cardiology Congress 2025

Miguel Rodriguez Ramos1, Gilberto Cairo Saez2
1 Independent researcher, Islas Canarias, Spain
2 Ministry of Public Health, Santa Clara, Villa Clara, Cuba

This article presents crucial results from clinical trials presented at the European Society of Cardiology Congress on the management of cardiovascular diseases. Relevant therapeutic updates for the coming years are offered while providing critical insights that inform clinical practice and lay the groundwork for future innovations, promising more effective and accessible solutions to the global burden of these diseases. Ref. 8, on-line full text (Free, PDF), www. cardiologyletters.sk

Kľúčové slová: cardiovascular disease; clinical trials

Uverejnené: May 1, 2025  Zobraziť citáciu

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rodriguez Ramos M, Saez GC. Pivotal clinical trials shaping contemporary cardiology practice. News from the European Society of Cardiology Congress 2025. Cardiology Letters. 2025;34(5-6):288-290.
Share...
Stiahnuť citáciu
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobraziť celý článok

    Referencie

    1. Bavendiek U, Großhennig A, Schwab J, Berliner D, Rieth A, Maier LS, et al. Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2025;393:1155-1165. doi: 10.1056/NEJMoa2415471. Prejsť k pôvodnému zdroju...
    2. Berg DD, Patel SM, Haller PM, Cange AL, Palazzolo MG, et al. Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure. Circulation. 2025 Aug 29. doi: 10.1161/CIRCULATIONAHA.125.076575. Prejsť k pôvodnému zdroju...
    3. Garcia-Pavia P, Maron MS, Masri A, Merkely B, Nassif ME, PeñaPeña ML, et al. Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy. N Engl J Med. 2025;393:949-960. doi: 10.1056/NEJMoa2504654. Prejsť k pôvodnému zdroju...
    4. Jøns C, Zheng C, Winsløw UCG, Danielsen EM, Sakthivel T, Frandsen EA, et al. Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias. N Engl J Med. 2025 Aug 29. doi: 10.1056/NEJMoa2509542. Prejsť k pôvodnému zdroju...
    5. Newby D, et al. Duration of dual antiplatelet therapy in acute coronary syndromes: the DUAL-ACS trial. Hotline 6, ESC Congress 2025, 29 August - 1 September, Madrid, Spain.
    6. Lemesle G, Didier R, Steg PG, Simon T, Montalescot G, Danchin N, et al. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. N Engl J Med. 2025 Aug 31. doi: 10.1056/NEJMoa2507532. Prejsť k pôvodnému zdroju...
    7. Flack JM, Azizi M, Brown JM, Dwyer JP, Fronczek J, Jones ESW, et al. Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. N Engl J Med. 2025 Aug 30:10.1056/ NEJMoa2507109. doi: 10.1056/NEJMoa2507109. Prejsť k pôvodnému zdroju...
    8. Wijesurendra R, Pessoa-Amorim G, Buck G, Harper C, Bulbulia R, Offer A, et al. Remote Screening for Asymptomatic Atrial Fibrillation: The AMALFI Randomized Clinical Trial. JAMA. 2025 Aug 29:e2515440. doi: 10.1001/jama.2025.15440. Prejsť k pôvodnému zdroju...

    Späť na obsah